Company Update BIOCON LTD. - 532523 - Notification To Stock Exchanges BSE India This is to inform you that our Active Pharmaceutical Ingredient (API) manufacturing facility located in Bangalore has received a certificate of GMP compliance from the Competent Authority of Germany, following an EU GMP inspection that was conducted in February 2023.